OCT 30, 2026 · JOURNAL ARTICLE
Transthyretin Amyloid Cardiomyopathy: Contemporary Pharmacological Management
European Cardiology Review
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive infiltrative cardiomyopathy increasingly recognised as a cause of heart failure. Advances in the understanding of it